141 related articles for article (PubMed ID: 18392696)
1. Mammary tumor development from T47-D human breast cancer cells in obese ovariectomized mice with and without estradiol supplements.
Nkhata KJ; Ray A; Dogan S; Grande JP; Cleary MP
Breast Cancer Res Treat; 2009 Mar; 114(1):71-83. PubMed ID: 18392696
[TBL] [Abstract][Full Text] [Related]
2. Alcohol consumption, obesity, estrogen treatment and breast cancer.
Hong J; Holcomb VB; Dang F; Porampornpilas K; Núñez NP
Anticancer Res; 2010 Jan; 30(1):1-8. PubMed ID: 20150611
[TBL] [Abstract][Full Text] [Related]
3. Diet-induced obesity and mammary tumor development in relation to estrogen receptor status.
Ray A; Nkhata KJ; Grande JP; Cleary MP
Cancer Lett; 2007 Aug; 253(2):291-300. PubMed ID: 17399892
[TBL] [Abstract][Full Text] [Related]
4. Effect of obesity on breast cancer development.
Cleary MP; Grossmann ME; Ray A
Vet Pathol; 2010 Mar; 47(2):202-13. PubMed ID: 20124008
[TBL] [Abstract][Full Text] [Related]
5. Estradiol supplementation helps overcome central leptin resistance of ovariectomized mice on a high fat diet.
Matysková R; Zelezná B; Maixnerová J; Koutová D; Haluzík M; Maletínská L
Horm Metab Res; 2010 Mar; 42(3):182-6. PubMed ID: 20049675
[TBL] [Abstract][Full Text] [Related]
6. Obesity increases the incidence of 7,12-dimethylbenz(a)anthracene-induced mammary tumors in an ovariectomized Zucker rat model.
Hakkak R; MacLeod S; Shaaf S; Holley AW; Simpson P; Fuchs G; Jo CH; Kieber-Emmons T; Korourian S
Int J Oncol; 2007 Mar; 30(3):557-63. PubMed ID: 17273756
[TBL] [Abstract][Full Text] [Related]
7. Obesity potentiates the growth and dissemination of pancreatic cancer.
Zyromski NJ; Mathur A; Pitt HA; Wade TE; Wang S; Nakshatri P; Swartz-Basile DA; Nakshatri H
Surgery; 2009 Aug; 146(2):258-63. PubMed ID: 19628082
[TBL] [Abstract][Full Text] [Related]
8. A dietary supplement for female sexual dysfunction, Avlimil, stimulates the growth of estrogen-dependent breast tumors (MCF-7) implanted in ovariectomized athymic nude mice.
Ju YH; Doerge DR; Helferich WG
Food Chem Toxicol; 2008 Jan; 46(1):310-20. PubMed ID: 17919800
[TBL] [Abstract][Full Text] [Related]
9. Vitamin D mitigates the adverse effects of obesity on breast cancer in mice.
Swami S; Krishnan AV; Williams J; Aggarwal A; Albertelli MA; Horst RL; Feldman BJ; Feldman D
Endocr Relat Cancer; 2016 Apr; 23(4):251-64. PubMed ID: 26817629
[TBL] [Abstract][Full Text] [Related]
10. Obesity and the associated mediators leptin, estrogen and IGF-I enhance the cell proliferation and early tumorigenesis of breast cancer cells.
Lautenbach A; Budde A; Wrann CD; Teichmann B; Vieten G; Karl T; Nave H
Nutr Cancer; 2009; 61(4):484-91. PubMed ID: 19838920
[TBL] [Abstract][Full Text] [Related]
11. Estrogen inhibits the effects of obesity and alcohol on mammary tumors and fatty liver.
Hong J; Holcomb VB; Kushiro K; Núñez NP
Int J Oncol; 2011 Dec; 39(6):1443-53. PubMed ID: 21850368
[TBL] [Abstract][Full Text] [Related]
12. Stereological analysis of estrogen receptor expression in the hypothalamic arcuate nucleus of ob/ob and agouti mice.
Chakraborty S; Sachdev A; Salton SR; Chakraborty TR
Brain Res; 2008 Jun; 1217():86-95. PubMed ID: 18502406
[TBL] [Abstract][Full Text] [Related]
13. Obesity and breast cancer: status of leptin and adiponectin in pathological processes.
Grossmann ME; Ray A; Nkhata KJ; Malakhov DA; Rogozina OP; Dogan S; Cleary MP
Cancer Metastasis Rev; 2010 Dec; 29(4):641-53. PubMed ID: 20821253
[TBL] [Abstract][Full Text] [Related]
14. Estrogen promotes tumor progression in a genetically defined mouse model of lung adenocarcinoma.
Hammoud Z; Tan B; Badve S; Bigsby RM
Endocr Relat Cancer; 2008 Jun; 15(2):475-83. PubMed ID: 18509000
[TBL] [Abstract][Full Text] [Related]
15. Antiestrogenic glyceollins suppress human breast and ovarian carcinoma tumorigenesis.
Salvo VA; Boué SM; Fonseca JP; Elliott S; Corbitt C; Collins-Burow BM; Curiel TJ; Srivastav SK; Shih BY; Carter-Wientjes C; Wood CE; Erhardt PW; Beckman BS; McLachlan JA; Cleveland TE; Burow ME
Clin Cancer Res; 2006 Dec; 12(23):7159-64. PubMed ID: 17145841
[TBL] [Abstract][Full Text] [Related]
16. RbAp46 inhibits estrogen-stimulated progression of neoplastigenic breast epithelial cells.
Zhang TF; Yu SQ; Wang ZY
Anticancer Res; 2007; 27(5A):3205-9. PubMed ID: 17970062
[TBL] [Abstract][Full Text] [Related]
17. N-butyldeoxynojirimycin causes weight loss as a result of appetite suppression in lean and obese mice.
Priestman DA; van der Spoel AC; Butters TD; Dwek RA; Platt FM
Diabetes Obes Metab; 2008 Feb; 10(2):159-66. PubMed ID: 18190430
[TBL] [Abstract][Full Text] [Related]
18. Novel human breast cancer cell lines IBH-4, IBH-6, and IBH-7 growing in nude mice.
Bruzzone A; Vanzulli SI; Soldati R; Giulianelli S; Lanari C; Lüthy IA
J Cell Physiol; 2009 May; 219(2):477-84. PubMed ID: 19194992
[TBL] [Abstract][Full Text] [Related]
19. Relationship of obesity to blood estrogens.
Zumoff B
Cancer Res; 1982 Aug; 42(8 Suppl):3289s-3294s. PubMed ID: 7083189
[TBL] [Abstract][Full Text] [Related]
20. Leptin signaling in breast cancer: an overview.
Cirillo D; Rachiglio AM; la Montagna R; Giordano A; Normanno N
J Cell Biochem; 2008 Nov; 105(4):956-64. PubMed ID: 18821585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
